Successful repair should be supported by evidence at two levels: restored myelin structure and improved axonal signaling. Structural measurements can show whether new myelin is present around nerve fibers, while nerve-conduction testing indicates whether those fibers transmit signals more effectively. Considering both prevents an anatomical change from being interpreted as functional recovery without corresponding evidence.
Each measurement addresses a different part of recovery. Histological staining, magnetic resonance imaging, and electron microscopy provide structural evidence related to myelin restoration, whereas nerve-conduction tests assess signaling through affected fibers. Combining these approaches gives a more reliable assessment than relying on one measurement, particularly when researchers need to determine whether repair has meaningful neurological consequences.
True repair should be supported by direct evidence of restored myelin rather than inferred only from reduced inflammation or improved symptoms. Structural findings from tissue-based methods or imaging can be compared with nerve-conduction results to test whether axonal signaling also improves. This distinction helps prevent temporary biological or clinical changes from being misclassified as regeneration.
Electron microscopy contributes detailed structural evidence about myelin and its relationship to nerve fibers. Its value is complementary to broader imaging and tissue-staining approaches because it helps examine repair at a more detailed level. In a multimodal assessment, these observations strengthen conclusions about whether newly detected changes represent restoration of myelin rather than an indirect effect of treatment.
Investigators can combine histological staining, magnetic resonance imaging, electron microscopy, and nerve-conduction testing to examine treatment effects from structural and functional perspectives. The resulting measurements are compared to determine whether a candidate therapy is associated with new myelin and better axonal signaling. This integrated approach supports comparison among treatments and helps separate repair from temporary changes.
It is particularly useful when studying recovery after demyelinating injury, assessing therapies for multiple sclerosis, or investigating other disorders involving myelin loss. The evaluation can characterize whether treatment-related changes reflect actual repair and whether that repair improves signaling. These findings support the development of regenerative therapies and provide evidence for comparing candidate interventions.